CP-461 is active alone and in combination with gemcitabine, vinorelbine, or irinotecan in non-small cell lung cancer cell lines.

被引：0
|
作者：
Schiller, J
Purvis, J
Bittner, G
机构：
[1] Cell Pathways Inc, Horsham, PA USA
[2] Univ Wisconsin, Madison, WI USA
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
661P
引用
收藏
页码：144 / 144
页数：1
相关论文
共 50 条
  • [21] Gemcitabine plus vinorelbine in elderly or unfit patients with non-small cell lung cancer
    Beretta, GD
    Michetti, G
    Belometti, MO
    Gritti, G
    Quadri, A
    Poletti, P
    Labianca, R
    BRITISH JOURNAL OF CANCER, 2000, 83 (05) : 573 - 576
  • [22] Gemcitabine (GEM) plus vinorelbine (NVB) in non-small cell lung cancer (NSCLC)
    Michetti, G
    Beretta, GD
    Belometti, MO
    Gritti, G
    Marini, B
    Agazzi, A
    Labianca, R
    ANNALS OF ONCOLOGY, 1998, 9 : 91 - 92
  • [23] Gemcitabine plus vinorelbine in elderly or unfit patients with non-small cell lung cancer
    G D Beretta
    G Michetti
    M O Belometti
    G Gritti
    A Quadri
    P Poletti
    R Labianca
    British Journal of Cancer, 2000, 83 : 573 - 576
  • [24] Gemcitabine and vinorelbine combinations in the treatment of non-small cell lung cancer - Discussion II
    Eckardt, JR
    Green, MR
    Gralla, RJ
    Langer, CJ
    Eastman, A
    Socinski, MA
    SEMINARS IN ONCOLOGY, 1999, 26 (05) : 71 - 72
  • [25] Cisplatin, ifosfamide and vinorelbine combination in advanced non-small cell lung cancer
    Baron, FJ
    Cueva, JF
    Vazquez, F
    Candamio, S
    Calvo, M
    Sanz, A
    Irigoyen, A
    Menendez, MD
    Huidobro, C
    Lopez, R
    ANNALS OF ONCOLOGY, 1998, 9 : 99 - 99
  • [26] Vinorelbine in the treatment of non-small cell lung cancer
    Gridelli, C
    De Vivo, R
    CURRENT MEDICINAL CHEMISTRY, 2002, 9 (08) : 879 - 891
  • [27] Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer
    Frasci, G
    Lorusso, V
    Panza, N
    Comella, P
    Nicolella, G
    Bianco, A
    De Cataldis, G
    Iannelli, A
    Bilancia, D
    Belli, M
    Massidda, B
    Piantedosi, F
    Comella, G
    De Lena, M
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (13) : 2529 - 2536
  • [28] Vinorelbine and gemcitabine is an effective and well tolerated combination for the treatment of patients with advanced non-small cell lung cancer.
    Beinert, T
    Kahnt, C
    Schweiger, M
    Fleischhacker, M
    Werner, TG
    Binder, D
    Mergenthaler, HG
    Possinger, K
    ANNALS OF ONCOLOGY, 2000, 11 : 110 - 110
  • [29] Phase mi study of Gemcitabine plus vinorelbine in non-small cell lung cancer (NSCLC)
    Puertas, J
    Esteban, E
    Fra, J
    Liano, JLG
    Vieitez, JM
    Estrada, E
    Palacio, I
    Muniz, I
    Buesa, JM
    Lacave, AJ
    ANNALS OF ONCOLOGY, 1998, 9 : 99 - 99
  • [30] Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter
    Juergens, Rosalyn
    Brahmer, Julie
    Ettinger, David
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (05) : 621 - 629
12345